Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Y Lau

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Cancer Chemotherapy and Pharmacology|April 3, 2013
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinomaStephen L Chan, Chi-Hang Wong, Cecilia P Y Lau, et al.
Investigational New Drugs|May 28, 2009
The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell linesBrigette B Y Ma, Vivian W Y Lui, Edwin P Hui, et al.
Investigational New Drugs|November 13, 2012
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell linesBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
International Journal of Molecular Sciences|March 28, 2026
Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast CancerKelsie L Thu, Soode Jafari, Jennifer Silvester, et al.
Investigational New Drugs|May 15, 2010
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinomaEdwin Pun Hui, Vivian W Y Lui, Cesar S C Wong, et al.
Investigational New Drugs|May 9, 2012
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell linesBrigette B Y Ma, Vivian W Y Lui, Crystal S Cheung, et al.
Cancer Letters|September 18, 2013
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer modelsBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
Oncogene|November 9, 2010
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell deathV W Y Lui, E Y L Wong, K Ho, et al.
British Journal of Cancer|December 24, 2010
Replication study of SNP associations for colorectal cancer in Hong Kong ChineseJ W Ho, S-c Choi, Y-f Lee, et al.
Oncogene|December 2, 2010
FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulationV W Y Lui, D M-S Yau, C S-F Cheung, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Cancer Chemotherapy and Pharmacology|April 3, 2013
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinomaStephen L Chan, Chi-Hang Wong, Cecilia P Y Lau, et al.
Investigational New Drugs|May 28, 2009
The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell linesBrigette B Y Ma, Vivian W Y Lui, Edwin P Hui, et al.
Investigational New Drugs|November 13, 2012
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell linesBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
International Journal of Molecular Sciences|March 28, 2026
Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast CancerKelsie L Thu, Soode Jafari, Jennifer Silvester, et al.
Investigational New Drugs|May 15, 2010
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinomaEdwin Pun Hui, Vivian W Y Lui, Cesar S C Wong, et al.
Investigational New Drugs|May 9, 2012
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell linesBrigette B Y Ma, Vivian W Y Lui, Crystal S Cheung, et al.
Cancer Letters|September 18, 2013
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer modelsBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
Oncogene|November 9, 2010
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell deathV W Y Lui, E Y L Wong, K Ho, et al.
British Journal of Cancer|December 24, 2010
Replication study of SNP associations for colorectal cancer in Hong Kong ChineseJ W Ho, S-c Choi, Y-f Lee, et al.
Oncogene|December 2, 2010
FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulationV W Y Lui, D M-S Yau, C S-F Cheung, et al.
Pageof 9